Anges MG develops gene therapy for chronic hepatitis B

The project will be ointly with US Vical Inc. which has proprietary gene transfer technology into the liver cell, and is in a preclinical stage. The concept is based on plasmid DNA which feeds into hepatocytes.

Anges MG news release, April 4, 2017

Most popular posts:

This website stores cookies on your computer. These cookies are used to provide a more personalized experience and to track your whereabouts around our website in compliance with the European General Data Protection Regulation. If you decide to to opt-out of any future tracking, a cookie will be setup in your browser to remember this choice for one year.

Accept or Deny